270 Life Sciences Private Capital Fund I LP — Form D
270 Life Sciences Private Capital Fund I LP of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2023-09-05. Industry: Pooled Investment Fund.
Offering
- Filed: 2023-09-05
- Form: D
- Accession: 0001959298-23-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-491365
Issuer
- Name: 270 Life Sciences Private Capital Fund I LP
- CIK: 0001959298
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 277 PARK AVENUE, FLOOR 23, NEW YORK, NY, 10017
- Phone: 917-216-5061
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Samantha Beattie | Executive Officer | New York, NY |
| Gaurav Gupta | Executive Officer | New York, NY |
| Patrick McGoldrick | Executive Officer | New York, NY |
| Anya Schiess | Executive Officer | New York, NY |
| EVAN SOTIRIOU | Executive Officer | NEW YORK, NY |
| Stephen Squinto | Executive Officer | Stamford, CT |
More